# ORA, Inc. clinical trials: 26 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials with ORA, Inc. as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by ORA, Inc.: 26 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/ora-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 16, 2025 | NCT07068958 | A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye | ORA, Inc. | Phase 2 | Not yet recruiting | Dry Eye Disease (DED) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07068958) |
| December 21, 2023 | NCT06178679 | Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease... | ORA, Inc. | Phase 3 | Unknown | Dry Eye Disease | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06178679) |
| June 22, 2023 | NCT05911555 | Mucin Levels in Dry Eye and Normal Populations | ORA, Inc. | Observational | Completed | Dry Eye | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05911555) |
| February 13, 2020 | NCT04268069 | Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye | ORA, Inc. | Phase 2 | Completed | Dry Eye Disease | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04268069) |
| October 3, 2018 | NCT03693456 | Food Allergy Diagnostic Test Response to Previous Oral Challenge Response | ORA, Inc. | Not applicable | Completed | Food Hypersensitivity | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03693456) |
| October 2, 2018 | NCT03693183 | Efficacy Study of Ketorolac and HPMC to Treat Dry Eye | ORA, Inc. | Phase 2 | Withdrawn | Dry Eye | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03693183) |
| October 25, 2017 | NCT03320434 | Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis | ORA, Inc. | Phase 2 | Completed | Allergic Conjunctivitis | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03320434) |
| September 8, 2017 | NCT03275753 | Visual Function Tests in Age-related Macular Degeneration | ORA, Inc. | Observational | Terminated | Age Related Macular Degeneration | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03275753) |
| March 23, 2017 | NCT03088605 | Safety and Efficacy of TOP1630 for Dry Eye Syndrome | ORA, Inc. | Phase 2 | Completed | Dry Eye Syndrome | 69 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03088605) |
| March 14, 2017 | NCT03079570 | Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance Levels | ORA, Inc. | Observational | Completed | Age Factor, Age-related Macular Degeneration | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03079570) |
| December 7, 2016 | NCT02985827 | Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra) | ORA, Inc. | Phase 4 | Completed | Dry Eye | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02985827) |
| November 17, 2015 | NCT02606721 | Food Allergy Challenge Diagnostic Study | ORA, Inc. | Observational | Completed | Food Hypersensitivity | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02606721) |
| December 4, 2014 | NCT02308501 | A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy | ORA, Inc. | Phase 4 | Completed | Allergic Conjunctivitis | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02308501) |
| November 24, 2014 | NCT02298400 | A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses | ORA, Inc. | Not applicable | Withdrawn | Contact Lens Complication | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02298400) |
| September 6, 2013 | NCT01936818 | Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen | ORA, Inc. | Observational | Completed | Allergic Rhinitis | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01936818) |
| November 21, 2012 | NCT01730872 | Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model | ORA, Inc. | Phase 4 | Completed | Chronic Allergic Conjunctivitis | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01730872) |
| March 8, 2012 | NCT01547936 | Effect of Controlled Adverse Environment (CAE) on Tear Film Stability | ORA, Inc. | Observational | Completed | Keratoconjunctivitis Sicca | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01547936) |
| February 16, 2012 | NCT01534195 | Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model | ORA, Inc. | Phase 4 | Completed | Allergic Conjunctivitis | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01534195) |
| September 23, 2011 | NCT01439815 | An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo | ORA, Inc. | Phase 4 | Completed | Allergic Rhinitis, Allergic Conjunctivitis | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01439815) |
| September 17, 2010 | NCT01204541 | A Single-Center Pilot Study to Assess Macular Function | ORA, Inc. | Observational | Completed | Macular Degeneration | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01204541) |
| February 26, 2010 | NCT01076439 | An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to... | ORA, Inc. | Phase 4 | Withdrawn | Allergic Rhinitis | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01076439) |
| September 28, 2009 | NCT00985296 | Conjunctival Allergen Challenge (CAC) Following Allergen Exposure in the Allergen BioCube (ABC) | ORA, Inc. | Observational | Completed | Allergic Rhinoconjunctivitis | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00985296) |
| September 28, 2009 | NCT00985075 | A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube | ORA, Inc. | Observational | Completed | Allergic Rhinoconjunctivitis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00985075) |
| September 23, 2009 | NCT00982163 | A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season | ORA, Inc. | Observational | Completed | Allergic Conjunctivitis | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00982163) |
| September 18, 2008 | NCT00755183 | Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction | ORA, Inc. | Phase 2 | Completed | Meibomian Gland Dysfunction | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00755183) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2 | 6 |
| Phase 3 | 1 |
| Phase 4 | 7 |
| Not applicable | 2 |
| Observational | 10 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 20 |
| Withdrawn | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Conjunctivitis, Allergic | 8 |
| Dry Eye Syndromes | 8 |
| Rhinitis, Allergic | 5 |
| Macular Degeneration | 3 |
| Food Hypersensitivity | 2 |
| Keratoconjunctivitis Sicca | 1 |
| Meibomian Gland Dysfunction | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Employment agencies in the United States](https://specstream.ai/data/businesses/employment-agencies/united-states)
- [Otology practices in the United States](https://specstream.ai/data/businesses/otology-practices/united-states)
- [Acupuncture clinics in the United States](https://specstream.ai/data/businesses/acupuncture-clinics/united-states)
- [Environmental abatement companies in the United States](https://specstream.ai/data/businesses/environmental-abatement-companies/united-states)
- [Patent law firms in the United States](https://specstream.ai/data/businesses/patent-law-firms/united-states)
- [Aircraft manufacturers in the United States](https://specstream.ai/data/businesses/aircraft-manufacturers/united-states)
